BridgeMD
New treatment option for Juvenile Myopia
Official title Assessment of DOT Spectacles in Chinese Children Extension
ClinicalTrials.gov ID: NCT07008001
What this study is testing
- What it's testing
- This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 16. Healthy volunteers may be eligible.
You may be able to join if
- Previously a successfully completed participant in the CATHAY study (NCT05562622)
- Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or...
- Willingness to participate in the trial for 12 months without contact lens wear or any other myopia management intervention
- The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of...
You likely can't join if
- 1\. Known allergy to proparacaine, tetracaine, or tropicamide or cyclopentolate
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, China
- Chengdu, China
- Guangzhou, China
- Shanghai, China
- Tianjin, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 16 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, China; Chengdu, China; Guangzhou, China; Shanghai, China; Tianjin, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.